Technical standards and guidelines:: Venous thromboembolism (Factor V Leiden and prothrombin 20210G>A testing):: A disease-specific supplement to the standards and guidelines for clinical genetics laboratories

被引：26
|
作者：
Spector, EB
Grody, WW
Matteson, CJ
Palomaki, GE
Bellissimo, DB
Wolff, DJ
Bradley, LA
Prior, TW
Feldman, G
Popovich, BW
Watson, MS
Richards, CS
机构：
[1] Amer Coll Med Genet, Lab Qual Assurance Mol Subcomm, Bethesda, MD 20914 USA
[2] Amer Coll Med Genet, Lab Qual Assurance Comm, Bethesda, MD USA
[3] Univ Colorado, Sch Med, Boulder, CO 80309 USA
[4] Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90024 USA
[5] Univ Tennessee, Med Ctr, Knoxville, TN 37996 USA
[6] Blood Ctr SE Wisconsin Inc, Milwaukee, WI 53201 USA
[7] Med Univ S Carolina, Charleston, SC 29425 USA
[8] Ctr Dis Control & Prevent, Atlanta, GA USA
[9] Ohio State Univ, Columbus, OH 43210 USA
[10] Wayne State Univ, Sch Med, Detroit, MI 48202 USA
[11] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
GENETICS IN MEDICINE | 2005年 / 7卷 / 06期
关键词：
factor V; prothrombin; thrombophilia;
D O I：
10.1097/01.GIM.0000172641.87755.3A
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：444 / 453
页数：10
相关论文
共 12 条
  • [1] The impact of family history of venous thromboembolism, factor V Leiden and prothrombin 20210G>A mutations, and acquired risk factors on the risk of venous thromboembolism
    Mili, F. D.
    Hooper, W. C.
    Lally, C.
    Austin, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 623 - 623
  • [2] ACMG Standards and Guidelines for fragile X testing: a revision to the disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics and Genomics
    Monaghan, Kristin G.
    Lyon, Elaine
    Spector, Elaine B.
    GENETICS IN MEDICINE, 2013, 15 (07) : 575 - 586
  • [3] Direct-to-consumer genetic testing for factor V Leiden and prothrombin 20210G>A: the consumer experience
    Elson, Sarah L.
    Furlotte, Nicholas A.
    Hromatka, Bethann S.
    Wilson, Catherine H.
    Mountain, Joanna L.
    Rowbotham, Helen M.
    Varga, Elizabeth A.
    Francke, Uta
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2020, 8 (11):
  • [4] Evaluation of the Molecular Testing for Factor V Leiden and Prothrombin 20210G>A Mutations: A Single Institute's Experience
    Bar, Y.
    Illoh, O. C.
    Nguyen, N. D.
    Oliver, D. H.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 574 - 574
  • [5] CLINICAL UTILITY OF GENETIC TESTING FOR FACTOR V LEIDEN AND PROTHROMBIN G20210A MUTATIONS IN PATIENTS WHO HAVE HAD A VENOUS THROMBOEMBOLISM
    Samal, L.
    Necochea, A.
    Crim, M. T.
    Emadi, A.
    Brotman, D. J.
    Wilson, L.
    Bass, E. B.
    Segal, J. B.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2009, 24 : 42 - 43
  • [6] THE ROLE OF FACTOR V LEIDEN 1691G>A AND PRO-THROMBIN 20210G>A MUTATIONS IN HYPERCOAGULABLE STATE ASSOCIATED WITH VENOUS THROMBOEMBOLISM AMONG SUDANESE PATIENTS
    Abdalla, Alfatih Aboalbasher
    Muddathir, Abdel Rahim M.
    Elamin, El-Waleed M.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2017, 39 : 3 - 3
  • [7] Recommendations from the EGAPP Working Group: Routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members
    Berg, Alfred O.
    Botkin, Jeffrey
    Calonge, Ned
    Campos-Outcalt, Doug
    Haddow, James E.
    Hayes, Maxine
    Kaye, Celia
    Klein, Roger D.
    Offit, Kenneth
    Pauker, Stephen G.
    Piper, Margaret
    Richards, Carolyn Sue
    Scott, Joan A.
    Strickland, Ora L.
    Teutsch, Steven
    Veenstra, David L.
    GENETICS IN MEDICINE, 2011, 13 (01) : 67 - 76
  • [8] American College of Medical Genetics and Genomics Standards and Guidelines for Clinical Genetics Laboratories, 2014 edition: technical standards and guidelines for Huntington disease (vol 16, e2, 2014)
    Bean, Lora
    Bayrak-Toydemir, Pinar
    GENETICS IN MEDICINE, 2021, 23 (12) : 2461 - 2461
  • [9] Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry
    Gadelha, Telma
    Roldan, Vanessa
    Lecumberri, Ramon
    Trujillo-Santos, Javier
    del Campo, Raquel
    Poggio, Renzo
    Monreal, Manuel
    THROMBOSIS RESEARCH, 2010, 126 (04) : 283 - 286
  • [10] CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS WITH FACTOR V LEIDEN OR PROTHROMBIN G20210A AND A FIRST EPISODE OF VENOUS THROMBOEMBOLISM. FINDINGS FROM THE RIETE REGISTRY
    Gadelha, T.
    Roldan, V.
    Lecumberri, R.
    Trujillo-Santos, J.
    Del Campo, R.
    Poggio, R.
    Monreal, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 64 - 65
12